Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,368.85
(
-1.67%
)
US TECH 100
22,653.20
(
0.67%
)
Dow Jones
45,166.64
(
0.00%
)
Brent Oil
107.45
(
-0.74%
)
Bitcoin
67,781.00
(
2.76%
)
News Focus
News Focus
Post# of 257302
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

rstor1

Send PM Follow Ignore
Followers 13
Posts 757
Boards Moderated 0
Alias Born 10/25/2003

rstor1

Re: DewDiligence post# 3681

Tuesday, 09/21/2004 5:36:13 PM

Tuesday, September 21, 2004 5:36:13 PM

Post# of 257302
+++Now, the inside of the machine's tubing has been coated to reduce the body's inflammatory response. +++

Alexion is has a MAB aimed at reducing the inflammatory response to CABG (biowatch - this is a competitor to tp-10). They did a study on the MAB vs placebo and found no improvement in cognitive impairment. Does not sound like the inflammation in itself is responsible.

Anyone here think PARS has a shot at this indication?

Bob


Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today